Xeris Biopharma Holdings, Inc. logo XERS - Xeris Biopharma Holdings, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $9.00 DETAILS
HIGH: $9.00
LOW: $9.00
MEDIAN: $9.00
CONSENSUS: $9.00
UPSIDE: 45.40%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Revenue
Revenue 83.1 85.8 74.4 71.5 60.1 60.1 54.3 48.1 40.6 44.4 48.3 38.0 33.2 33.1 29.7 25.3 22.1 21.7 11.0 8.9 8.2 7.2 9.4 2.0 1.8 1.9 0.3 0.3 0.2 0.8 0.6 0.8 0.3 0.5 0.2 0.6 0.4
Cost of Revenue 13.3 19.1 11.0 14.6 8.7 9.5 13.6 10.5 6.0 10.3 8.2 7.6 5.3 6.3 5.3 4.8 6.3 4.9 3.2 3.4 1.8 3.4 2.8 1.3 1.8 1.6 0.0 0.0 0 0.0 0 0 0.0 0 0 0.0 0
Gross Profit 69.8 66.7 63.4 56.9 51.4 50.6 40.7 37.6 34.7 34.1 40.1 30.5 27.9 26.9 24.5 20.5 15.8 16.8 7.8 5.5 6.4 3.8 6.6 0.7 (0.0) 0.3 0.3 0.3 0.2 0.8 0.6 0.8 0.2 0.5 0.2 0.6 0.4
Operating Expenses
R&D Expenses 8.8 7.9 7.5 8.1 7.8 6.1 5.9 5.8 7.8 6.4 5.0 6.1 4.8 5.0 6.0 3.7 6.2 10.1 5.7 5.4 4.0 5.1 3.9 5.3 6.6 12.4 15.5 19.3 13.2 12.4 10.9 8.7 8.7 6.6 5.7 4.2 3.7
SG&A Expenses 53.1 47.5 46.5 44.4 44.0 40.1 45.0 40.0 38.4 37.6 37.3 37.6 33.6 34.4 34.5 33.0 35.9 54.2 26.5 25.9 19.1 18.0 16.5 17.6 21.6 20.6 14.9 15.0 12.5 8.7 4.7 4.5 3.2 3.1 2.0 1.6 1.3
Other Expenses 0 (5.4) 2.7 0 2.7 2.7 2.7 0 2.7 0 2.7 2.7 2.7 2.7 2.7 2.7 2.7 0.8 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 61.9 50.0 56.7 52.4 54.5 48.9 53.6 45.8 48.9 44.0 45.0 46.4 41.2 42.0 43.2 39.4 44.9 65.1 32.2 31.3 23.1 23.1 20.4 22.9 28.3 33.1 30.4 34.4 25.7 21.1 15.5 13.2 12.0 9.7 7.7 5.8 5.0
Operating Income
Operating Income 7.9 16.8 6.7 4.5 (3.1) 1.7 (12.9) (8.2) (14.2) (9.8) (4.9) (16.0) (13.3) (15.2) (18.8) (18.9) (29.1) (48.3) (24.4) (25.8) (16.7) (19.3) (13.7) (22.2) (28.3) (32.8) (30.1) (34.1) (25.4) (20.3) (14.9) (12.4) (11.7) (9.2) (7.6) (5.2) (4.6)
Interest Expense 6.9 7.2 7.3 7.4 7.3 7.7 7.8 8.0 7.0 7.0 6.8 6.5 6.2 4.4 4.0 3.4 3.5 1.8 1.8 1.8 1.8 4.6 2.3 2.2 1.5 1.5 3.5 1.1 1.1 1.1 0.7 0.6 0.2 0.0 0 0.0 0
Interest Income 1.2 1.5 1.2 0.9 1.2 0.9 1.2 1.3 1.9 1.1 1.1 1.2 1.3 1.8 0.5 0.2 0.1 0.1 0.1 0.1 0.1 2.0 0.2 0.3 0.4 0.6 0.7 0.8 0.7 0.8 0.5 0.2 0.1 0.1 0.0 0 0
Profitability
EBITDA 11.1 14.1 11.1 8.6 1.2 5.7 (8.2) (3.1) (8.4) (3.3) (2.3) (10.6) (7.4) (5.4) (15.1) (20.0) (27.6) (48.1) (23.9) (25.4) (16.3) (16.8) (13.3) (21.6) (27.4) (31.6) (29.0) (33.1) (24.1) (19.2) (14.0) (12.3) (11.7) (9.1) (7.5) (5.2) (4.6)
EBIT 7.9 11.1 7.9 5.4 (1.9) 2.6 (11.3) (6.3) (11.6) (6.6) (5.7) (14.0) (10.6) (8.9) (18.2) (23.1) (30.6) (49.0) (24.2) (25.7) (16.6) (17.3) (13.7) (22.0) (27.7) (32.0) (29.3) (33.3) (24.2) (19.4) (14.0) (12.4) (11.7) (9.1) (7.5) (5.2) (4.6)
Income Before Tax 2.2 11.1 0.6 (1.9) (9.2) (5.1) (19.1) (14.3) (18.7) (13.6) (12.5) (20.5) (16.8) (13.3) (22.2) (26.5) (34.1) (50.8) (26.0) (27.5) (18.4) (21.9) (16) (24.2) (29.2) (33.5) (32.8) (34.4) (25.3) (20.4) (14.8) (13.0) (11.9) (9.1) (7.5) (5.2) (4.6)
Income Tax Expense 0 0 0 0 0 0 (3.3) 0.7 0.3 (0.2) (0.3) (0.7) 0 (0.3) (0.3) (0.3) (0.4) 0 0 0 0 0 0 (0.1) 0 (0.5) 0 0 0 0 0 0 0 0 0.0 0.0 0
Net Income 2.2 11.1 0.6 (1.9) (9.2) (5.1) (15.7) (15.0) (19.0) (13.4) (12.2) (19.8) (16.8) (12.9) (21.8) (26.2) (33.7) (50.8) (26.0) (27.5) (18.4) (21.9) (16) (24.1) (29.2) (33.1) (32.8) (34.4) (25.3) (20.4) (14.8) (13.0) (11.9) (9.1) (7.5) (5.2) (4.6)
Per Share Data
EPS (Basic) 0.01 0.07 0.00 -0.01 -0.06 -0.03 -0.11 -0.10 -0.14 -0.10 -0.09 -0.14 -0.12 -0.10 -0.16 -0.19 -0.25 -0.42 -0.39 -0.41 -0.30 -0.41 -0.35 -0.63 -0.89 -1.23 -1.22 -1.28 -1.07 -0.98 -1.81 -3.07 -5.49 -4.43 -3.72 -2.59 -2.29
EPS (Diluted) 0.01 0.06 0.00 -0.01 -0.06 -0.03 -0.11 -0.10 -0.14 -0.10 -0.09 -0.14 -0.12 -0.10 -0.16 -0.19 -0.25 -0.42 -0.39 -0.41 -0.30 -0.41 -0.35 -0.63 -0.89 -1.23 -1.22 -1.28 -1.07 -0.98 -1.81 -3.07 -5.49 -4.43 -3.72 -2.59 -2.29
Shares Outstanding 170.5 166.0 177.6 156.0 152.4 149.1 149.0 148.3 140.5 138.1 138.1 137.3 137.1 136.0 136.0 135.5 135.0 121.7 66.5 66.4 61.2 53.5 46.1 38.0 32.8 27.0 26.9 26.9 23.6 20.8 8.1 4.2 2.2 2.1 2.0 2.0 2.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q1
Current Assets
Cash & Cash Equivalents 111.8 111.0 91.6 59.3 58.4 71.6 59.2 57.6 62.7 67.4 46.1 46.2 51.0 122.0 84.1 95.3 103.8 67.3 59.5 63.6 66.6 37.6 37.9 102.5 39.2 19.5 56.2 66.7 62.0 45.7 75.7 134.5 58.1 42.0 (32.3)
Short-Term Investments 0 0 0 0 0 0 10.2 20.0 24.7 5.0 19.8 34.5 44.1 0 9.3 16.2 28.4 35.2 33.5 52.4 69.3 96.2 103.9 41.5 57.7 56.0 46.3 57.8 85.7 66.9 55.3 0 0 0 64.5
Net Receivables 56.3 51.0 53.8 53.0 46.3 40.4 41.1 42.4 37.4 39.2 46.0 30.2 30.9 30.8 27.5 25.8 23.4 17.5 13.6 12.3 8.9 6.9 12.2 3.9 3.3 4.7 0.9 0.8 3.6 2.9 1.7 1.1 0.3 1.2 0
Inventory 74.2 68.7 67.5 67.3 52.7 48.2 45.1 43.0 40.9 38.8 38.1 36.5 29.0 24.7 20.1 17.9 16.9 18.1 14.2 12.3 12.5 8.4 5.6 4.8 2.2 2.2 0 0 0 0 0 0 0 0 0
Other Current Assets 9.4 9.5 11.2 6.0 6.0 7.5 7.1 7.4 7.6 5.8 8.0 8.3 10.5 9.3 0 6.0 5.1 0 3.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 251.7 240.3 224.0 185.6 163.5 167.7 162.8 170.3 173.3 156.3 158.1 155.7 165.5 186.8 148.9 161.2 177.6 142.6 124.4 144.6 160.6 152.2 163.2 156.4 105.5 87.5 106.0 126.1 153.4 117.9 135.7 137.0 59.8 44.1 32.3
Non-Current Assets
Property, Plant & Equipment 27.0 27.1 27.2 27.7 27.8 28.2 28.4 28.7 28.8 29.2 29.6 30.2 10.4 9.5 5.8 6.2 6.3 6.6 6.7 6.7 6.8 6.7 6.9 7.4 7.6 7.9 8.0 7.7 7.4 2.0 1.8 1.1 1.1 0.8 0
Goodwill 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 22.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 85.4 88.1 90.8 93.5 96.2 98.9 101.6 104.3 107.1 109.8 112.5 115.2 117.9 120.6 123.3 126.0 128.7 131.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 4.1 4.1 0 4.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.8 3.0 13.2 13.9 0 0 0 0 0 0 0 0
Other Non-Current Assets 5.1 5.2 5.3 5.1 1.0 1.3 5.4 1.3 4.6 4.5 4.8 4.8 4.7 4.7 2.2 2.4 2.2 0.8 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.7 0.2 (32.3)
Total Non-Current Assets 140.3 143.2 146.2 149.1 152.0 155.4 158.3 161.4 163.3 166.3 169.7 173.0 155.8 157.7 154.1 157.4 160.1 161.8 6.9 6.9 7.0 6.9 7.2 9.4 10.9 21.5 22.1 7.7 7.5 2.1 1.9 1.2 1.7 0.9 (32.3)
Total Assets 392.0 383.5 370.2 334.7 315.5 323.1 321.1 331.7 336.6 322.6 327.8 328.8 321.4 344.5 303.0 318.6 337.6 304.4 131.3 151.5 167.6 159.2 170.4 165.8 116.5 109.0 128.1 133.9 161.0 120.0 137.6 138.3 61.6 45.0 0
Current Liabilities
Account Payables 11.5 3.1 6.5 9.5 6.4 2.3 7.5 5.8 7.1 11.6 12.1 11.6 12.0 4.6 3.9 6.6 11.1 8.9 4.3 5.2 4.8 3.1 4.7 4.4 3.8 5.6 1.7 1.8 1.4 0.9 0.6 0.6 0.8 2.0 0
Short-Term Debt 6.3 6.2 6.2 0 12.0 15.1 15.1 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.2 0.2 0.2 0.3 0.3 0.3 0.2 0
Other Current Liabilities 100.9 100.3 103.5 36.5 32.4 39.7 34.8 51.6 26.8 51.4 43.7 40.6 39.7 27.2 18.4 17.6 19.4 25.6 5.9 6.5 3.5 4.0 11.1 3.3 2.5 2.2 11.3 0.6 1.5 5.0 4.8 2.8 1.4 0.3 0
Total Current Liabilities 118.6 109.6 116.2 95.2 95.1 100.4 91.0 75.5 73.1 95.2 87.0 79.7 81.4 73.6 68.6 64.5 66.5 79.0 37.3 35.5 27.4 28.2 27.0 22.8 21.9 27.3 17.8 21.0 13.4 10.2 8.2 9.2 9.2 4.9 0
Non-Current Liabilities
Long-Term Debt 31.1 31.5 32.0 218.6 217.8 217.0 216.2 230.5 229.7 190.9 190.4 188.2 187.6 187.1 138.5 138.1 137.6 88.1 87.7 87.5 87.3 87.0 119.4 109.5 58.5 58.3 58.1 29.4 32.1 31.9 31.6 18.2 18.1 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 3.3 2.6 2.3 2.5 2.8 3.5 3.5 3.9 4.2 4.5 4.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 229.4 228.7 222.9 7.8 4.8 2.0 8.5 7.7 6.1 6.2 8.8 9.6 9.4 25.7 37.1 37.9 32.5 37.1 8.7 8.7 8.6 10.2 9.6 9.2 9.0 8.9 8.5 8.7 8.3 2.6 2.6 1.6 1.5 98.0 0
Total Non-Current Liabilities 260.4 260.3 254.9 258.8 255.5 252.2 258.4 275.5 272.7 234.2 236.9 235.5 209.9 225.7 179.4 180.1 174.7 130.1 96.4 96.1 95.8 97.2 129.0 118.6 67.5 67.2 66.7 38.1 40.5 34.5 34.3 19.7 19.5 98.0 0
Total Liabilities 379.0 369.8 371.1 354.0 350.6 352.7 349.4 351.0 345.8 329.4 323.9 315.1 291.3 299.3 248.0 244.7 241.2 209.1 133.7 131.6 123.2 125.4 156.1 141.4 89.4 94.6 84.4 59.1 53.9 44.6 42.5 28.9 28.7 102.8 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (669.1) (671.3) (682.4) (683.0) (681.1) (671.9) (666.7) (651.0) (636.0) (617.0) (603.6) (591.4) (571.6) (554.8) (541.8) (520.0) (493.8) (460.1) (409.3) (383.3) (355.8) (337.4) (315.5) (299.5) (275.4) (246.2) (213.2) (180.3) (145.9) (120.7) (100.2) (85.5) (72.5) (60.6) 0
Accumulated Other Comprehensive Income (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) (0.0) (0.0) (0.0) 0.0 0.1 0.2 0.1 0.0 0.0 0.1 (0.0) (0.1) (0.1) 0 (102.3) (0.4) (31.9)
Total Stockholders' Equity 13.0 13.7 (0.9) (19.3) (35.1) (29.6) (28.3) (19.3) (9.2) (6.8) 3.9 13.6 30.0 45.2 55.0 73.9 96.5 95.2 (2.5) 19.9 44.4 33.8 14.3 24.4 27.1 14.4 43.7 74.8 107.1 75.4 95.1 109.3 32.9 (57.8) 31.0
Total Liabilities & Equity 392.0 383.5 370.2 334.7 315.5 323.1 321.1 331.7 336.6 322.6 327.8 328.8 321.4 344.5 303.0 318.6 337.6 304.4 131.3 151.5 167.6 159.2 170.4 165.8 116.5 109.0 128.1 133.9 161.0 120.0 137.6 138.3 61.6 45.0 31.0
Debt Metrics
Total Debt 37.3 37.8 38.2 257.2 268.8 271.4 271.0 269.8 268.7 229.2 227.9 225.0 198.4 198.1 138.5 138.1 138.0 88.1 87.7 87.5 87.3 87.0 119.4 109.5 58.5 58.3 58.1 32.4 32.1 31.9 31.6 18.2 18.1 0 0
Net Debt (74.4) (73.3) (53.4) 197.9 210.3 199.8 211.7 212.2 206.0 161.7 181.8 178.8 147.4 76.1 54.4 42.7 34.2 20.8 28.2 23.9 20.7 49.4 81.5 7.0 19.2 38.8 2.0 (34.3) (29.8) (13.8) (44.1) (116.4) (40.1) (42.0) 32.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Operating Activities
Net Income 2.2 11.1 0.6 (1.9) (9.2) (5.1) (15.7) (15.0) (19.0) (13.4) (12.2) (19.8) (16.8) (12.9) (21.8) (26.2) (33.7) (50.8) (26.0) (27.5) (18.4) (21.9) (16) (24.1) (29.2) (33.1) (32.8) (34.4) (25.3) (20.4) (14.8) (13.0) (11.9) (9.1) (7.5) (5.2) (4.6)
Depreciation & Amortization 3.0 3.0 3.0 3.2 3.1 3.1 2.7 3.2 3.2 3.3 3.4 3.4 3.2 3.5 3.1 3.1 3.0 0.9 0.3 0.3 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 0 5.3 7.6 5.0 4.4 3.6 6.8 4.2 3.8 2.8 2.5 2.9 2.6 2.8 2.9 3.2 3.3 2.7 3.7 2.5 2.5 2.1 2.1 2.1 2.0 1.8 1.8 1.7 1.1 0.6 0.5 0.4 0.2 0.1 0.1 0.1 0.2
Change in Working Capital (0.6) (0.4) 6.1 (6.9) (9.2) (0.5) 9.0 (3.4) (5.6) 17.8 (10.7) 0.4 (13.9) (3.0) (2.5) (5.4) (24.2) 17.1 (0.8) 4.3 (8.7) 5.9 (4.0) (2.7) (2.1) 1.3 (2.2) 9.3 3.3 1.4 (1.4) (2.1) 3.7 (0.2) 1.8 (1.4) 0.9
Other Non-Cash Items 5.2 1.0 1.0 0.8 0.8 0.8 (7.7) (0.1) (3.0) (2.9) (0.4) (0.2) (0.8) (6.5) 0.3 4.8 3.2 0.2 0.2 0.2 0.3 2.4 0.3 0.2 0.2 0.2 0.3 0.3 0.3 0.2 0.2 0.1 0.0 0.1 1.2 0.0 0.6
Operating Cash Flow 9.9 20.0 18.4 0.2 (10.0) 2.0 (8.3) (10.3) (20.3) 6.3 (14.6) (13.7) (26.1) (16.1) (17.8) (20.6) (48.4) (28.9) (22.6) (20.0) (24.0) (10.9) (17.0) (23.8) (28.9) (29.6) (30.6) (23.0) (21.2) (18.3) (15.9) (14.2) (7.8) (9.1) (5.6) (6.5) (3.5)
Investing Activities
Capital Expenditure (0.3) (0.3) (0.4) (0.3) (0.0) (0.2) (0.1) (0.4) (0.2) (0.1) (0.3) (1.5) (0.2) (0.1) (0.2) (0.2) 0.0 (0.1) (0.3) (0.2) (0.4) (0.2) 0.0 (0.1) (0.0) (0.2) (0.4) (0.3) (0.2) (0.2) (0.8) (0.2) (0.3) (0.2) (0.0) (0.1) (0.3)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0.0 38.5 0.3 0.2 0.4 0.2 0 0 0.0 0.2 0.4 0.3 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 (5.0) (5) (24.5) 0 0 0 (43.7) 0 0 0.0 0 (12.2) (10.6) (12.2) (7.9) (10.4) (77.7) 0 (13.7) (26.5) (29.7) (8.4) (37.8) (13.6) (55.3) 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 10.2 15 10 5 15 15 10 0 9.3 6.9 12.1 6.7 10.5 29.4 29 34.6 17.8 17 17.5 22.4 17.7 27.6 36.6 19.3 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0.3 0 0 0 0 0 0 0 0 10 (43.7) 0 6.9 (0.0) 6.7 (1.7) (0.3) (0.2) (0.4) (0.2) 0.0 17.5 (0.0) (0.2) (0.4) (0.3) (18.5) 2.1 (55.3) 0 0 0 0 0 0
Investing Cash Flow (0.3) (0.3) (0.1) (0.3) (0.0) 10.0 9.9 4.6 (19.6) 14.9 14.7 8.5 (44.0) 9.2 6.7 11.9 6.7 36.6 18.5 16.6 26.3 7.2 (60.7) 17.3 8.7 (9.0) (2.5) 27.9 (18.7) (11.7) (56.0) (0.2) (0.3) (0.2) (0.0) (0.1) (0.3)
Financing Activities
Net Debt Issuance 0 9.2 0 0 0 0 0 0 38.2 0 0 0 0 48.9 0 0 53.8 0 0 0 0 3.5 11.2 0 0 0 25 0 0 0 15 0 20 0 0 0 0
Stock Repurchased (17.0) (1.5) (0.5) (0.9) (8.0) (0.2) (0.1) (0.1) (3.4) (0.0) (0.1) (0.0) (0.9) (0.0) (0.0) (0.0) (0.4) (0.2) 0 0 (0.4) 0 0 0 (0.1) 0 0 3.9 (3.9) 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 4.9 0.6 0 0.7 0.5 0 0 0.6 0 0.3 (0.2) 0.3 24.8 0.3 0.0 0.5 0.0 (0.2) 1.8 49.5 (2.6) 2.0 (2.4) (0.2) 0.1 0.0 (1.8) (7.5) 4.2 0.0 0.0 (0.0) (0.4)
Financing Cash Flow (8.8) (0.3) 13.8 0.9 (3.1) 0.4 (0.1) 0.7 35.2 (0.0) (0.1) 0.6 (0.9) 49.2 (0.2) 0.3 78.2 0.1 0.0 0.5 26.7 3.3 13.1 69.6 40.1 2.0 22.6 (0.2) 56.1 0.0 13.2 90.8 24.2 5.5 0.0 30.0 (0.4)
Cash Position
Net Change in Cash 0.7 19.4 32.2 0.8 (13.2) 12.4 1.5 (5.1) (4.8) 21.3 (0.0) (4.7) (71.0) 42.2 (11.2) (8.4) 36.5 7.8 (4.1) (3.0) 29.0 (0.3) (64.6) 63.2 19.7 (36.6) (10.5) 4.7 16.3 (30.0) (58.8) 76.4 16.1 (3.9) (5.6) 23.5 (4.2)
Cash at Beginning 111.0 95.6 63.4 62.6 75.7 63.4 61.8 62.7 67.4 46.1 50.6 55.3 126.3 84.1 95.3 103.8 67.3 59.5 63.6 66.6 37.6 37.9 102.5 39.2 19.5 56.2 66.7 62.0 45.7 75.7 134.5 58.1 42.0 45.9 51.5 28.0 32.3
Cash at End 111.8 115.1 95.6 63.4 62.6 75.7 63.4 57.6 62.7 67.4 50.6 50.6 55.3 126.3 84.1 95.3 103.8 67.3 59.5 63.6 66.6 37.6 37.9 102.5 39.2 19.5 56.2 66.7 62.0 45.7 75.7 134.5 58.1 42.0 45.9 51.5 28.0
Free Cash Flow 9.5 19.7 18.1 (0.1) (10.0) 1.8 (8.4) (10.7) (20.5) 6.2 (15.0) (15.3) (26.4) (16.3) (17.9) (20.8) (48.4) (29.1) (22.9) (20.2) (24.4) (11.1) (17.0) (23.9) (29.0) (29.8) (31.0) (23.3) (21.4) (18.6) (16.7) (14.4) (8.1) (9.3) (5.6) (6.6) (3.9)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Income Statement
Revenue 83.1 85.8 74.4 71.5 60.1 60.1 54.3 48.1 40.6 44.4 48.3 38.0 33.2 33.1 29.7 25.3 22.1 21.7 11.0 8.9 8.2 7.2 9.4 2.0 1.8 1.9 0.3 0.3 0.2 0.8 0.6 0.8 0.3 0.5 0.2 0.6 0.4
Gross Profit 69.8 66.7 63.4 56.9 51.4 50.6 40.7 37.6 34.7 34.1 40.1 30.5 27.9 26.9 24.5 20.5 15.8 16.8 7.8 5.5 6.4 3.8 6.6 0.7 (0.0) 0.3 0.3 0.3 0.2 0.8 0.6 0.8 0.2 0.5 0.2 0.6 0.4
Operating Income 7.9 16.8 6.7 4.5 (3.1) 1.7 (12.9) (8.2) (14.2) (9.8) (4.9) (16.0) (13.3) (15.2) (18.8) (18.9) (29.1) (48.3) (24.4) (25.8) (16.7) (19.3) (13.7) (22.2) (28.3) (32.8) (30.1) (34.1) (25.4) (20.3) (14.9) (12.4) (11.7) (9.2) (7.6) (5.2) (4.6)
Net Income 2.2 11.1 0.6 (1.9) (9.2) (5.1) (15.7) (15.0) (19.0) (13.4) (12.2) (19.8) (16.8) (12.9) (21.8) (26.2) (33.7) (50.8) (26.0) (27.5) (18.4) (21.9) (16) (24.1) (29.2) (33.1) (32.8) (34.4) (25.3) (20.4) (14.8) (13.0) (11.9) (9.1) (7.5) (5.2) (4.6)
EPS (Diluted) 0.01 0.06 0.00 -0.01 -0.06 -0.03 -0.11 -0.10 -0.14 -0.10 -0.09 -0.14 -0.12 -0.10 -0.16 -0.19 -0.25 -0.42 -0.39 -0.41 -0.30 -0.41 -0.35 -0.63 -0.89 -1.23 -1.22 -1.28 -1.07 -0.98 -1.81 -3.07 -5.49 -4.43 -3.72 -2.59 -2.29
Balance Sheet
Cash & Equivalents 111.8 111.0 91.6 59.3 58.4 71.6 59.2 57.6 62.7 67.4 46.1 46.2 51.0 122.0 84.1 95.3 103.8 67.3 59.5 63.6 66.6 37.6 37.9 102.5 39.2 19.5 56.2 66.7 62.0 45.7 75.7 134.5 58.1 42.0 (32.3)
Total Assets 392.0 383.5 370.2 334.7 315.5 323.1 321.1 331.7 336.6 322.6 327.8 328.8 321.4 344.5 303.0 318.6 337.6 304.4 131.3 151.5 167.6 159.2 170.4 165.8 116.5 109.0 128.1 133.9 161.0 120.0 137.6 138.3 61.6 45.0 0
Total Debt 37.3 37.8 38.2 257.2 268.8 271.4 271.0 269.8 268.7 229.2 227.9 225.0 198.4 198.1 138.5 138.1 138.0 88.1 87.7 87.5 87.3 87.0 119.4 109.5 58.5 58.3 58.1 32.4 32.1 31.9 31.6 18.2 18.1 0 0
Stockholders' Equity 13.0 13.7 (0.9) (19.3) (35.1) (29.6) (28.3) (19.3) (9.2) (6.8) 3.9 13.6 30.0 45.2 55.0 73.9 96.5 95.2 (2.5) 19.9 44.4 33.8 14.3 24.4 27.1 14.4 43.7 74.8 107.1 75.4 95.1 109.3 32.9 (57.8) 31.0
Cash Flow
Operating Cash Flow 9.9 20.0 18.4 0.2 (10.0) 2.0 (8.3) (10.3) (20.3) 6.3 (14.6) (13.7) (26.1) (16.1) (17.8) (20.6) (48.4) (28.9) (22.6) (20.0) (24.0) (10.9) (17.0) (23.8) (28.9) (29.6) (30.6) (23.0) (21.2) (18.3) (15.9) (14.2) (7.8) (9.1) (5.6) (6.5) (3.5)
Capital Expenditure (0.3) (0.3) (0.4) (0.3) (0.0) (0.2) (0.1) (0.4) (0.2) (0.1) (0.3) (1.5) (0.2) (0.1) (0.2) (0.2) 0.0 (0.1) (0.3) (0.2) (0.4) (0.2) 0.0 (0.1) (0.0) (0.2) (0.4) (0.3) (0.2) (0.2) (0.8) (0.2) (0.3) (0.2) (0.0) (0.1) (0.3)
Free Cash Flow 9.5 19.7 18.1 (0.1) (10.0) 1.8 (8.4) (10.7) (20.5) 6.2 (15.0) (15.3) (26.4) (16.3) (17.9) (20.8) (48.4) (29.1) (22.9) (20.2) (24.4) (11.1) (17.0) (23.9) (29.0) (29.8) (31.0) (23.3) (21.4) (18.6) (16.7) (14.4) (8.1) (9.3) (5.6) (6.6) (3.9)